Sumesh Eswaran

Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents.

A. V. Adhikari, N. Pal, Sumesh Eswaran, 2010, Bioorganic & medicinal chemistry letters.

Synthesis Development of the Selective Estrogen Receptor Degrader (SERD) LSZ102 from a Suzuki Coupling to a C–H Activation Strategy

Peng Fu, Krishnaswamy Devanathan, Sumesh Eswaran, 2020 .

New quinoline derivatives: synthesis and investigation of antibacterial and antituberculosis properties.

A. V. Adhikari, N. Pal, K. Thomas, 2010, European journal of medicinal chemistry.

A multi-targeting pre-clinical candidate against drug-resistant tuberculosis.

N. Loman, G. Besra, S. Narayanan, 2021, Tuberculosis.

Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1,2,4-triazole moiety.

A. V. Adhikari, Sumesh Eswaran, N. S. Shetty, 2009, European journal of medicinal chemistry.

Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety.

S. Narayanan, S. Subramanian, Sumesh Eswaran, 2019, Bioorganic & Medicinal Chemistry Letters.

Design, Synthesis and Study of Antibacterial and Antitubercular Activity of Quinoline Hydrazone Hybrids

S. Subramanian, Sumesh Eswaran, Shruthi T G, 2020 .

New 1,3-oxazolo[4,5-c]quinoline derivatives: synthesis and evaluation of antibacterial and antituberculosis properties.

A. V. Adhikari, R. Ajay Kumar, Sumesh Eswaran, 2010, European journal of medicinal chemistry.